HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenichi Hamagami Selected Research

Enteropeptidase

1/2022Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity.
10/2019SCO-792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenichi Hamagami Research Topics

Disease

3Obesity
01/2022 - 01/2017
2Body Weight (Weight, Body)
10/2019 - 01/2017
1Insulin Resistance
10/2019
1Liver Diseases (Liver Disease)
10/2019
1Weight Loss (Weight Reduction)
01/2017

Drug/Important Bio-Agent (IBA)

2EnteropeptidaseIBA
01/2022 - 10/2019
14-guanidinobenzoateIBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1Biological ProductsIBA
01/2022
1EstersIBA
01/2022
1N- (((3S)- 6- ((4- carbamimidamidobenzoyl)oxy)- 2,3- dihydro- 1- benzofuran- 3- yl)acetyl)- L- aspartic acid hydrateIBA
10/2019
1Alanine Transaminase (SGPT)IBA
10/2019
1Essential Amino AcidsIBA
10/2019
1Glucose (Dextrose)FDA LinkGeneric
10/2019
1LipidsIBA
10/2019
1bombesin receptor subtype 3IBA
01/2017

Therapy/Procedure

2Oral Administration
01/2022 - 01/2017